Antioxidants regulators in VALI
VALI 中的抗氧化剂调节剂
基本信息
- 批准号:7548530
- 负责人:
- 金额:$ 42.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Acute Lung InjuryAntioxidantsCanis familiarisCellsClinical ResearchCollaborationsComplexDevelopmentEnzymesEpithelial CellsEventFamily memberGene ProteinsGeneticGenomicsHumanHyperoxiaInjuryKnock-outKnockout MiceLungMechanical ventilationMolecularMolecular GeneticsMolecular ProfilingMolecular TargetMusNF-E2-related factor 2OxidantsOxidative StressPhasePlayProductionProtein OverexpressionProteinsProteomicsReactive Oxygen SpeciesResearch Project GrantsRoleStressStretchingSystemTechniquesTestingTranscription Factor AP-1Transgenic MiceUp-RegulationValidationVentilatorbasefos-related antigen 1insightlung injurymutantprotein expressionrepairedresponsetranscription factor
项目摘要
The overall aim of this SCCOR application is to understand the complex events related to ventilator-associated lung injury (VALI). In Project 6, we will determine the role of oxidative stress in VALI. Oxidative stress has been generally implicated in acute lung injury through production of reactive oxygen species (ROS). To detoxify ROS, lung cells express a network of integrated antioxidant enzymes (AOE) consisting of both classical and phase II detoxifying enzymes. However, if the oxidant stress is overwhelming, ROS may suppress or inactivate the AOE system resulting in cellular damage. We have recently shown by genetic and
functional analysis that NF-E2 related factor 2 (Nrf2) plays a critical role in hyperoxia-induced lung injury. This transcription factor is involved in lung epithelial cell repair and stretch and regulates the induction of phase II AOEs. We have also shown that Nrf2-knockout mice are more susceptible to hyperoxia-induced lung injury. In collaboration with the various Cores of the SCCOR, genomic analysis revealed an upregulation of Nrf2 and AP-1 family members, such as fos-related protein-1 (Fra-1), as well as specific AOEs in the lungs of mice and dogs exposed to mechanical ventilation (MV). Thus, we hypothesize that activation of transcription factors such as Nrf2 and Fra-1 and their downstream effectors plays a critical role in the modulation of VALI. To test this hypothesis, we propose the following Specific Aims: 1) Determine the molecular responses of the lung in response to MV and hyperoxia in the development of VALI. We will compare gene and protein expression profiles and markers of injury in the lungs of mice and
dogs exposed to MV and hyperoxia; 2) Examine the role of Nrf2 and identify its downstream effectors in VALI; and 3) Examine the role of Fra-1 and identify its downstream effectors in VALI. For these studies, we will use respective knockout and/or transgenic mice with specific lung overexpression of mutant or wildtype proteins of Nrf2 and Fra-1, as well as genomics and proteomics techniques in collaboration with the various Cores. Cross species comparison and validation of these results in human will be done through collaboration with other Basic and Clinical Research Projects, respectively. Results of these studies will provide further insight into the role of oxidative stress as well as the molecular and genetic basis of VALI. The identification
of molecular targets will aid in the development of new strategies aimed at minimizing the potential I hazardous effects of MV and hyperoxia.
此 SCCOR 应用的总体目标是了解与呼吸机相关肺损伤 (VALI) 相关的复杂事件。在项目 6 中,我们将确定氧化应激在 VALI 中的作用。氧化应激通常与活性氧 (ROS) 产生引起的急性肺损伤有关。为了解毒 ROS,肺细胞表达一个由经典解毒酶和 II 期解毒酶组成的整合抗氧化酶 (AOE) 网络。然而,如果氧化应激势不可挡,ROS 可能会抑制或灭活 AOE 系统,从而导致细胞损伤。我们最近通过遗传和
功能分析表明NF-E2相关因子2(Nrf2)在高氧诱导的肺损伤中发挥着关键作用。该转录因子参与肺上皮细胞修复和拉伸,并调节 II 期 AOE 的诱导。我们还表明,Nrf2 敲除小鼠更容易受到高氧引起的肺损伤。与 SCCOR 的各个核心合作,基因组分析揭示了 Nrf2 和 AP-1 家族成员的上调,例如 fos 相关蛋白 1 (Fra-1),以及小鼠和狗肺部的特定 AOE暴露于机械通气(MV)。因此,我们假设 Nrf2 和 Fra-1 等转录因子及其下游效应子的激活在 VALI 的调节中发挥着关键作用。为了检验这一假设,我们提出以下具体目标:1)确定肺在 VALI 发展过程中对 MV 和高氧的分子反应。我们将比较小鼠肺部的基因和蛋白质表达谱以及损伤标志物,
暴露于MV和高氧环境的狗; 2)考察Nrf2在VALI中的作用并鉴定其下游效应子; 3) 检查 Fra-1 的作用并确定其在 VALI 中的下游效应器。对于这些研究,我们将使用具有特定肺过表达 Nrf2 和 Fra-1 突变型或野生型蛋白的相应敲除和/或转基因小鼠,以及与各个 Core 合作的基因组学和蛋白质组学技术。这些结果在人类中的跨物种比较和验证将分别通过与其他基础和临床研究项目的合作来完成。这些研究的结果将进一步深入了解氧化应激的作用以及 VALI 的分子和遗传基础。鉴定
分子靶标的研究将有助于制定新策略,旨在最大限度地减少 MV 和高氧的潜在危险影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sekhar P. Reddy其他文献
Sekhar P. Reddy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sekhar P. Reddy', 18)}}的其他基金
Role of Nrf2 in Alveolar Epithelial Cell Regeneration During Lung Repair
Nrf2 在肺修复过程中肺泡上皮细胞再生中的作用
- 批准号:
10025798 - 财政年份:2020
- 资助金额:
$ 42.71万 - 项目类别:
Role of Nrf2 in Alveolar Epithelial Cell Regeneration During Lung Repair
Nrf2 在肺修复过程中肺泡上皮细胞再生中的作用
- 批准号:
9289190 - 财政年份:2017
- 资助金额:
$ 42.71万 - 项目类别:
Fra-1-A20 Signaling and Resolution of Pneumonia-Induced Sepsis
Fra-1-A20 信号传导和肺炎引起的败血症的解决
- 批准号:
9906946 - 财政年份:2017
- 资助金额:
$ 42.71万 - 项目类别:
ROLE OF NRF2 IN ALVEOLAR EPITHELIAL REGENERATION DURING LUNG REPAIR
NRF2 在肺修复过程中肺泡上皮再生中的作用
- 批准号:
9351722 - 财政年份:2017
- 资助金额:
$ 42.71万 - 项目类别:
Targeting Fra-1 in Toxicant-Induced Lung Tumor Initiation & Development
靶向 Fra-1 参与毒物诱导的肺肿瘤发生
- 批准号:
8212283 - 财政年份:2011
- 资助金额:
$ 42.71万 - 项目类别:
Targeting Fra-1 in Toxicant-Induced Lung Tumor Initiation & Development
靶向 Fra-1 参与毒物诱导的肺肿瘤发生
- 批准号:
8049523 - 财政年份:2011
- 资助金额:
$ 42.71万 - 项目类别:
Targeting Fra-1 in Toxicant-Induced Lung Tumor Initiation & Development
靶向 Fra-1 参与毒物诱导的肺肿瘤发生
- 批准号:
8268753 - 财政年份:2011
- 资助金额:
$ 42.71万 - 项目类别:
The Role and Biology of Fra-1 in Lung Injury and Repair
Fra-1 在肺损伤和修复中的作用和生物学
- 批准号:
7847936 - 财政年份:2009
- 资助金额:
$ 42.71万 - 项目类别:
相似国自然基金
农用地膜抗氧化剂的土壤污染特征及其微生物效应与机制研究
- 批准号:42377223
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
塑料抗氧化剂内分泌干扰转化产物的识别与环境行为研究
- 批准号:22306042
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
取代对苯二胺抗氧化剂及其醌衍生物的人体内暴露标志物研究
- 批准号:22306031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗氧化剂/活性离子时序释放复合支架构建及其修复糖尿病骨缺损的机制研究
- 批准号:32360232
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
长江口盐度梯度下光诱导氯自由基驱动纳塑料老化及其抗氧化剂的抑制作用
- 批准号:42377372
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Preclinical development of AST-004 for astrocyte-mediated treatment of TBI.
用于星形胶质细胞介导的 TBI 治疗的 AST-004 的临床前开发。
- 批准号:
9788532 - 财政年份:2015
- 资助金额:
$ 42.71万 - 项目类别:
Thioredoxin mimicry: novel treatment of toxicant-mediated inhalational lung injur
硫氧还蛋白拟态:毒物介导的吸入性肺损伤的新治疗方法
- 批准号:
8735374 - 财政年份:2014
- 资助金额:
$ 42.71万 - 项目类别:
Novel Means to Establish Free Radical Balance in the Neonatal Premature Lung
在新生儿早产儿肺中建立自由基平衡的新方法
- 批准号:
8124570 - 财政年份:2011
- 资助金额:
$ 42.71万 - 项目类别:
Multifunctional therapeutics for treatment of acute chlorine inhalational injury
治疗急性氯气吸入性损伤的多功能疗法
- 批准号:
8336844 - 财政年份:2011
- 资助金额:
$ 42.71万 - 项目类别:
Multifunctional therapeutics for treatment of acute chlorine inhalational injury
治疗急性氯气吸入性损伤的多功能疗法
- 批准号:
8539619 - 财政年份:2011
- 资助金额:
$ 42.71万 - 项目类别: